Excellergy Inc is a startup based in the United States, most recent round Series A.
Excellergy Inc is a startup based in the United States. Its most recent tracked round is Series A.
Excellergy Inc develops a novel class of allergy therapeutics called Effector Cell Response Inhibitors (ECRIs) that disable the IgE axis to rapidly and effectively control severe allergic diseases by removing IgE from allergic effector cells and preventing re-sensitization.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.